Valuation : Teleflex Incorporated

Market Cap 5.95B 5.13B 4.83B 4.4B 8.27B 565B 8.32B 57.1B 22.22B 287B 22.35B 21.86B 953B P/E 2026 *
37.6x
P/E 2027 * 17.3x
Enterprise Value 7.33B 6.32B 5.95B 5.42B 10.19B 696B 10.25B 70.32B 27.37B 354B 27.52B 26.93B 1,174B EV / Sales 2026 *
3.23x
EV / Sales 2027 * 2.92x
Free-Float
87.47%
Yield 2026 *
0.97%
Yield 2027 * 0.98%
1 day-1.11%
1 week+0.21%
Current month-1.11%
1 month+2.76%
3 months+10.12%
6 months+15.09%
Current year+15.11%
1 week 135.2
Extreme 135.2
143.05
1 month 130.03
Extreme 130.0331
145
Current year 100.18
Extreme 100.18
145
1 year 100.18
Extreme 100.18
145
3 years 100.18
Extreme 100.18
257.85
5 years 100.18
Extreme 100.18
405.9
10 years 100.18
Extreme 100.18
449.38
Manager TitleAgeSince
Chief Executive Officer - 08/06/2026
Director of Finance/CFO - 02/04/2025
Compliance Officer - 01/01/2018
Director TitleAgeSince
Director/Board Member 66 01/01/2009
Director/Board Member 72 01/05/2015
Director/Board Member 70 13/09/2016
Date Insider Type Main position Quantity % Market Cap. Importance
5/15/26 A Free

Director

3,487 0.0079%
5/15/26 A Free

Director

5,883 0.0133%
5/15/26 A Free

Chairman

3,487 0.0079%
Change 5-day change 1-year change 3-year change Capi.($)
-1.11%+0.21% - - 6.02B
Average -1.11%
Weighted average by Cap. -1.11%

Financials

2026 *2027 *
Net sales 2.27B 1.96B 1.84B 1.68B 3.15B 215B 3.17B 21.76B 8.47B 110B 8.52B 8.33B 363B 2.37B 2.04B 1.92B 1.75B 3.29B 225B 3.31B 22.7B 8.84B 114B 8.89B 8.69B 379B
Net income 121M 104M 98.12M 89.39M 168M 11.48B 169M 1.16B 451M 5.84B 454M 444M 19.36B 171M 148M 139M 126M 238M 16.23B 239M 1.64B 639M 8.26B 642M 628M 27.38B
Net Debt 1.38B 1.19B 1.12B 1.02B 1.92B 131B 1.93B 13.22B 5.15B 66.55B 5.18B 5.06B 221B 960M 828M 779M 709M 1.33B 91.07B 1.34B 9.21B 3.58B 46.33B 3.6B 3.52B 154B
Logo Teleflex Incorporated
Teleflex Incorporated is a global provider of medical technologies. The Company offers a diverse portfolio with solutions in the therapy areas of anesthesia, emergency medicine, interventional cardiology and radiology, surgical, and vascular access. It primarily designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. It operates in three segments: the Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). Its vascular access product portfolio includes Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous (bone access) systems. Its interventional product offerings consist of a portfolio of the MANTA Vascular Closure device, Arrow OnControl powered bone biopsy system, GuideLiner, Turnpike and TrapLiner catheters.
Employees
15,500
Date Price Change Volume
01/09/26 $140.48 -1.11% 565,006
31/08/26 $142.05 +1.70% 653,146
28/08/26 $139.67 +1.42% 429,358
27/08/26 $137.71 -0.74% 370,575
26/08/26 $138.74 -1.03% 533,769
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
140.48USD
Average target price
153.55USD
Spread / Average Target
+9.30%

Quarterly revenue - Rate of surprise